Cellectis Eulerpool naujienos

Cellectis Eulerpool News

Cellectis akcijų naujienos

Cellectis stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Cellectis naujienas mes pateikiame čia.

• liepos 25 d. ·

  Yahoo
  FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
• liepos 25 d. ·

  TipRanks
  Cellectis Gains FDA Designations for Leukemia Therapy
• liepos 25 d. ·

  Thefly.com
  FDA grants Cellectis' UCART22 ODD and RPDD status for ALL treatment
• liepos 23 d. ·

  Thefly.com
  Cellectis treatment of acute lymphoblastic leukemia granted orphan designation
• liepos 12 d. ·

  Yahoo
  Regenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains?
• liepos 10 d. ·

  Yahoo
  Down -22.78% in 4 Weeks, Here's Why You Should You Buy the Dip in Cellectis (CLLS)
• liepos 5 d. ·

  Yahoo
  Monthly information on share capital and company voting rights
• birželio 28 d. ·

  TipRanks
  Cellectis Shareholders Approve Key Resolutions
• birželio 28 d. ·

  TipRanks
  Cellectis Shareholders Support Management’s Vision
• birželio 26 d. ·

  GlobeNewswire
  Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits